Johnson & Johnson (JNJ) Net Margin Growth (5y) (2014 - 2026)

Johnson & Johnson (JNJ) Net Margin Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 -601.00
Dec 28, 2025 1,309.00
Sep 28, 2025 461.00
Jun 29, 2025 355.00
Mar 30, 2025 2,223.00
Dec 31, 2023 -1,530.00
Oct 1, 2023 8,239.00
Jul 2, 2023 -2,006.00
Apr 2, 2023 -1,980.00
Jan 1, 2023 5,452.00
Oct 2, 2022 -1,842.00
Jul 3, 2022 -1,758.00
Apr 3, 2022 -2,198.00
Oct 3, 2021 -826.00
Jul 4, 2021 530.00
Apr 4, 2021 227.00
Jan 3, 2021 -1,337.00
Sep 27, 2020 -278.00
Jun 28, 2020 -561.00
Mar 29, 2020 315.00